V-ATPase F, or V-type proton ATPase subunit F, is an integral component of the vacuolar ATPase (V-ATPase) complex, which plays a crucial role in acidifying a variety of intracellular compartments in eukaryotic cells. This acidification is vital for numerous cellular processes, including protein sorting, zymogen activation, and the coupling of energy metabolism with proton transport. V-ATPase operates by hydrolyzing ATP to ADP, a process that provides the energy necessary to pump protons across biological membranes, thereby generating an electrochemical proton gradient. This gradient is essential for the transport of molecules across membranes, pH homeostasis, and various signaling pathways. The functional regulation of V-ATPase and, by extension, its F subunit, is tightly linked to the energetic and metabolic status of the cell, reflecting its critical role in cellular physiology.
Activation of V-ATPase F and the V-ATPase complex as a whole involves several mechanisms, including reversible assembly of the V0 and V1 sectors, phosphorylation, and interactions with various cytosolic and membrane-associated proteins. The reversible assembly/disassembly mechanism is particularly notable for its role in responding to cellular energy levels and pH requirements, enabling the cell to rapidly adjust the activity of V-ATPase in accordance with metabolic demands. Moreover, the regulation of V-ATPase activity can be modulated by the direct binding of small molecules or ions to specific subunits, which may alter the conformation of the enzyme and thereby its activity. Specific signaling pathways, such as those mediated by cAMP or calcium ions, also play a role in modulating V-ATPase activity by affecting its assembly and localization within the cell. This complex regulatory framework ensures that V-ATPase activity is finely tuned to the cell's needs, enabling efficient proton transport and acidification processes essential for maintaining cellular homeostasis and supporting various physiological functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fusicoccin | 20108-30-9 | sc-200754 sc-200754A sc-200754B | 1 mg 5 mg 10 mg | $416.00 $2081.00 $4162.00 | 7 | |
Fusicoccin A leads to the activation of H+-ATPase by stabilizing the binding of 14-3-3 proteins to the plasma membrane H+-ATPase. Stabilized H+-ATPase can indirectly enhance the activity of V-ATPase F by promoting acidification processes in cells. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
Similar to Bafilomycin A1, Concanamycin A is a V-ATPase inhibitor that can be used to increase V-ATPase F activity post-inhibition through a compensatory cellular response. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc is a trace element that can act as a cofactor in various enzymatic reactions. It is essential for the proper folding and function of many proteins, potentially including the V-ATPase F subunit. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
Lysophosphatidic acid (LPA) influences a number of signaling pathways, including those that regulate intracellular pH. By modulating pH homeostasis, LPA could indirectly enhance the activity of V-ATPase F. | ||||||
Copper(II) sulfate | 7758-98-7 | sc-211133 sc-211133A sc-211133B | 100 g 500 g 1 kg | $46.00 $122.00 $189.00 | 3 | |
Copper is a metal ion that can serve as a cofactor for various enzymes. While not a direct activator, copper can influence the structural integrity and potentially the activity of V-ATPase F. | ||||||
Oligomycin | 1404-19-9 | sc-203342 sc-203342C | 10 mg 1 g | $149.00 $12495.00 | 18 | |
Oligomycin is an inhibitor of the mitochondrial ATP synthase. Chronic treatment with oligomycin may lead to a compensatory upregulation of V-ATPase F due to the need to maintain proton gradients. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Amiloride is primarily known as an inhibitor of Na+/H+ exchange. By inhibiting this exchange, amiloride may indirectly increase the demand for V-ATPase F activity to maintain cellular proton balance. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP, which can lead to the activation of PKA and subsequent phosphorylation of proteins. This signaling cascade may indirectly enhance the activity of V-ATPase F. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine raises the pH of acidic vesicles, which may lead to a compensatory upregulation of V-ATPase F activity in order to restore the pH gradient. | ||||||